Jingni Hui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jingni Hui has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Feng Zhang
Xi’an Jiaotong University
6 shared publications Xuena Yang
NHC Key Laboratory of Environment and Endemic Diseases, School of Public Health, Health Science Center, Xi’an Jiaotong University
5 shared publicationsDan He
NHC Key Laboratory of Environment and Endemic Diseases, School of Public Health, Health Science Center, Xi’an Jiaotong University
4 shared publications- Bolun Cheng
Key Laboratory of Trace Elements and Endemic Diseases of National Health and Family Planning Commission, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education of China, Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, School of Public Health, Health Science Center, Xi’an Jiaotong University, Xi’an, China
3 shared publications Shiqiang Cheng
NHC Key Laboratory of Environment and Endemic Diseases, School of Public Health, Health Science Center, Xi’an Jiaotong University
3 shared publications- Shiqiang Cheng
Key Laboratory of Trace Elements and Endemic Diseases of National Health and Family Planning Commission, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education of China, Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, School of Public Health, Health Science Center, Xi’an Jiaotong University, Xi’an, China
3 shared publications
Latest Publications
- 31 August 2026
- Published by Elsevier in Joint Bone Spine
- Vol. 93 (6)
Plasma metabolic and proteomic signatures of mixed exposure to ambient air pollutants associated with incident arthritis subtypes
- 31 August 2026
- Published by Elsevier in Joint Bone Spine
- Vol. 93 (6)
Plasma metabolic and proteomic signatures of mixed exposure to ambient air pollutants associated with incident arthritis subtypes
- 5 June 2026
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 27 (6) , 634-645
Dynamical proteomic signatures for depression across preclinical stages in 52,121 individuals from a prospective cohort study
To characterise proteomic changes associated with depression risk across different follow-up periods and develop predictive models integrating protein and clinical features. Olink proteomic data from the UK Biobank were analysed using logistic regression and Cox proportional hazards models to identify depression-associated proteins. Time-specific analyses were performed within 1-, 5-, and 10-year follow-up windows. Depression was defined using ICD-10 codes. GO and KEGG enrichment analyses were conducted, and predictive proteins were selected using sequential forward selection prior to XGBoost modelling. Among 52,121 participants, 2,442 developed depression. Distinct plasma protein signatures were identified across followup windows. Within 1 year, BRK1, MME, LRPAP1, and LRP1 were significantly associated with depression. Within 5 years, MMP12, SPP1, and SPON2 were among 287 unique associated proteins, while TGM2, OMG, and UBAC1 were representative markers among 509 proteins identified within 10 years. LEP was consistently selected across all time windows and in the overall population. The combined protein-clinical XGBoost model achieved the best performance within the 1-year follow-up window (AUC = 0.808, 95% CI: 0.696-0.911), outperforming protein-only and clinical-only models. Circulating plasma proteins have predictive value for depression risk, with LEP emerging as a robust biomarker across multiple time horizons.
- 5 June 2026
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 27 (6) , 634-645
Dynamical proteomic signatures for depression across preclinical stages in 52,121 individuals from a prospective cohort study
To characterise proteomic changes associated with depression risk across different follow-up periods and develop predictive models integrating protein and clinical features. Olink proteomic data from the UK Biobank were analysed using logistic regression and Cox proportional hazards models to identify depression-associated proteins. Time-specific analyses were performed within 1-, 5-, and 10-year follow-up windows. Depression was defined using ICD-10 codes. GO and KEGG enrichment analyses were conducted, and predictive proteins were selected using sequential forward selection prior to XGBoost modelling. Among 52,121 participants, 2,442 developed depression. Distinct plasma protein signatures were identified across followup windows. Within 1 year, BRK1, MME, LRPAP1, and LRP1 were significantly associated with depression. Within 5 years, MMP12, SPP1, and SPON2 were among 287 unique associated proteins, while TGM2, OMG, and UBAC1 were representative markers among 509 proteins identified within 10 years. LEP was consistently selected across all time windows and in the overall population. The combined protein-clinical XGBoost model achieved the best performance within the 1-year follow-up window (AUC = 0.808, 95% CI: 0.696-0.911), outperforming protein-only and clinical-only models. Circulating plasma proteins have predictive value for depression risk, with LEP emerging as a robust biomarker across multiple time horizons.
- 26 December 2024
- Published by Elsevier in Joint Bone Spine
- Vol. 92 (3) , 105841
A large-scale multi-omics polygenic risk score analysis identified candidate risk locus associated with rheumatoid arthritis
- 26 December 2024
- Published by Elsevier in Joint Bone Spine
- Vol. 92 (3) , 105841
A large-scale multi-omics polygenic risk score analysis identified candidate risk locus associated with rheumatoid arthritis
- Open Access
- 6 August 2024
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-12
Single-cell multiomics analysis reveals cell/tissue-specific associations in bipolar disorder
This study investigates the cellular origin and tissue heterogeneity in bipolar disorder (BD) by integrating multiomics data. Four distinct datasets were employed, including single-cell RNA sequencing (scRNA-seq) data (embryonic and fetal brain, n = 8, 1,266 cells), BD Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) data (adult brain, n = 210), BD bulk RNA-seq data (adult brain, n = 314), and BD genome-wide association study (GWAS) summary data (n = 413,466). The integration of scRNA-seq data with multiomics data relevant to BD was accomplished using the single-cell disease relevance score (scDRS) algorithm. We have identified a novel brain cell cluster named ADCY1, which exhibits distinct genetic characteristics. From a high-resolution genetic perspective, glial cells emerge as the primary cytopathology associated with BD. Specifically, astrocytes were significantly related to BD at the RNA-seq level, while microglia showed a strong association with BD across multiple panels, including the transcriptome-wide association study (TWAS), ATAC-seq, and RNA-seq. Additionally, oligodendrocyte precursor cells displayed a significant association with BD in both ATAC-seq and RNA-seq panel. Notably, our investigation of brain regions affected by BD revealed significant associations between BD and all three types of glial cells in the dorsolateral prefrontal cortex (DLPFC). Through comprehensive analyses, we identified several BD-associated genes, including CRMP1, SYT4, UCHL1, and ZBTB18. In conclusion, our findings suggest that glial cells, particularly in specific brain regions such as the DLPFC, may play a significant role in the pathogenesis of BD. The integration of multiomics data has provided valuable insights into the etiology of BD, shedding light on potential mechanisms underlying this complex psychiatric disorder.
- 6 August 2024
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-12
Open AccessSingle-cell multiomics analysis reveals cell/tissue-specific associations in bipolar disorder
This study investigates the cellular origin and tissue heterogeneity in bipolar disorder (BD) by integrating multiomics data. Four distinct datasets were employed, including single-cell RNA sequencing (scRNA-seq) data (embryonic and fetal brain, n = 8, 1,266 cells), BD Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) data (adult brain, n = 210), BD bulk RNA-seq data (adult brain, n = 314), and BD genome-wide association study (GWAS) summary data (n = 413,466). The integration of scRNA-seq data with multiomics data relevant to BD was accomplished using the single-cell disease relevance score (scDRS) algorithm. We have identified a novel brain cell cluster named ADCY1, which exhibits distinct genetic characteristics. From a high-resolution genetic perspective, glial cells emerge as the primary cytopathology associated with BD. Specifically, astrocytes were significantly related to BD at the RNA-seq level, while microglia showed a strong association with BD across multiple panels, including the transcriptome-wide association study (TWAS), ATAC-seq, and RNA-seq. Additionally, oligodendrocyte precursor cells displayed a significant association with BD in both ATAC-seq and RNA-seq panel. Notably, our investigation of brain regions affected by BD revealed significant associations between BD and all three types of glial cells in the dorsolateral prefrontal cortex (DLPFC). Through comprehensive analyses, we identified several BD-associated genes, including CRMP1, SYT4, UCHL1, and ZBTB18. In conclusion, our findings suggest that glial cells, particularly in specific brain regions such as the DLPFC, may play a significant role in the pathogenesis of BD. The integration of multiomics data has provided valuable insights into the etiology of BD, shedding light on potential mechanisms underlying this complex psychiatric disorder.
- Open Access
Micronutrient-Associated Single Nucleotide Polymorphism and Mental Health: A Mendelian Randomization Study
Purpose: Previous studies have demonstrated the link between micronutrients and mental health. However, it remains uncertain whether this connection is causal. We aim to investigate the potential causal effects of micronutrients on mental health based on linkage disequilibrium score (LDSC) regression and Mendelian randomization (MR) analysis. Methods: Utilizing publicly available genome-wide association study (GWAS) summary datasets, we performed LDSC and MR analysis to identify candidate micronutrients with potential causal effects on mental health. Single nucleotide polymorphisms (SNPs) significantly linked with candidate micronutrients with a genome-wide significance level (p < 5 × 10−8) were selected as instrumental variables (IVs). To estimate the causal effect of candidate micronutrients on mental health, we employed inverse variance weighted (IVW) regression. Additionally, two sensitivity analyses, MR-Egger and weighted median, were performed to validate our results. Results: We found evidence supporting significant causal associations between micronutrients and mental health. LDSC detected several candidate micronutrients, including serum iron (genetic correlation = −0.134, p = 0.032) and vitamin C (genetic correlation = −0.335, p < 0.001) for attention-deficit/hyperactivity disorder (ADHD), iron-binding capacity (genetic correlation = 0.210, p = 0.037) for Alzheimer’s disease (AD), and vitamin B12 (genetic correlation = −0.178, p = 0.044) for major depressive disorder (MDD). Further MR analysis suggested a potential causal relationship between vitamin B12 and MDD (b = −0.139, p = 0.009). There was no significant heterogeneity or pleiotropy, indicating the validity of the findings. Conclusion: In this study, we identified underlying causal relationships between micronutrients and mental health. Notably, more research is necessary to clarify the underlying biological mechanisms by which micronutrients affect mental health.
Open AccessMicronutrient-Associated Single Nucleotide Polymorphism and Mental Health: A Mendelian Randomization Study
Purpose: Previous studies have demonstrated the link between micronutrients and mental health. However, it remains uncertain whether this connection is causal. We aim to investigate the potential causal effects of micronutrients on mental health based on linkage disequilibrium score (LDSC) regression and Mendelian randomization (MR) analysis. Methods: Utilizing publicly available genome-wide association study (GWAS) summary datasets, we performed LDSC and MR analysis to identify candidate micronutrients with potential causal effects on mental health. Single nucleotide polymorphisms (SNPs) significantly linked with candidate micronutrients with a genome-wide significance level (p < 5 × 10−8) were selected as instrumental variables (IVs). To estimate the causal effect of candidate micronutrients on mental health, we employed inverse variance weighted (IVW) regression. Additionally, two sensitivity analyses, MR-Egger and weighted median, were performed to validate our results. Results: We found evidence supporting significant causal associations between micronutrients and mental health. LDSC detected several candidate micronutrients, including serum iron (genetic correlation = −0.134, p = 0.032) and vitamin C (genetic correlation = −0.335, p < 0.001) for attention-deficit/hyperactivity disorder (ADHD), iron-binding capacity (genetic correlation = 0.210, p = 0.037) for Alzheimer’s disease (AD), and vitamin B12 (genetic correlation = −0.178, p = 0.044) for major depressive disorder (MDD). Further MR analysis suggested a potential causal relationship between vitamin B12 and MDD (b = −0.139, p = 0.009). There was no significant heterogeneity or pleiotropy, indicating the validity of the findings. Conclusion: In this study, we identified underlying causal relationships between micronutrients and mental health. Notably, more research is necessary to clarify the underlying biological mechanisms by which micronutrients affect mental health.
- Open Access
- 22 January 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 25 (2)
Enhanced polygenic risk score incorporating gene–environment interaction suggests the association of major depressive disorder with cardiac and lung function
Depression has been linked to an increased risk of cardiovascular and respiratory diseases; however, its impact on cardiac and lung function remains unclear, especially when accounting for potential gene–environment interactions. We developed a novel polygenic and gene–environment interaction risk score (PGIRS) integrating the major genetic effect and gene–environment interaction effect of depression-associated loci. The single nucleotide polymorphisms (SNPs) demonstrating major genetic effect or environmental interaction effect were obtained from genome-wide SNP association and SNP-environment interaction analyses of depression. We then calculated the depression PGIRS for non-depressed individuals, using smoking and alcohol consumption as environmental factors. Using linear regression analysis, we assessed the associations of PGIRS and conventional polygenic risk score (PRS) with lung function (N = 42 886) and cardiac function (N = 1791) in the subjects with or without exposing to smoking and alcohol drinking. We detected significant associations of depression PGIRS with cardiac and lung function, contrary to conventional depression PRS. Among smokers, forced vital capacity exhibited a negative association with PGIRS (β = −0.037, FDR = 1.00 × 10−8), contrasting with no significant association with PRS (β = −0.002, FDR = 0.943). In drinkers, we observed a positive association between cardiac index with PGIRS (β = 0.088, FDR = 0.010), whereas no such association was found with PRS (β = 0.040, FDR = 0.265). Notably, in individuals who both smoked and drank, forced expiratory volume in 1-second demonstrated a negative association with PGIRS (β = −0.042, FDR = 6.30 × 10−9), but not with PRS (β = −0.003, FDR = 0.857). Our findings underscore the profound impact of depression on cardiac and lung function, highlighting the enhanced efficacy of considering gene–environment interactions in PRS-based studies.
- 22 January 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 25 (2)
Open AccessEnhanced polygenic risk score incorporating gene–environment interaction suggests the association of major depressive disorder with cardiac and lung function
Depression has been linked to an increased risk of cardiovascular and respiratory diseases; however, its impact on cardiac and lung function remains unclear, especially when accounting for potential gene–environment interactions. We developed a novel polygenic and gene–environment interaction risk score (PGIRS) integrating the major genetic effect and gene–environment interaction effect of depression-associated loci. The single nucleotide polymorphisms (SNPs) demonstrating major genetic effect or environmental interaction effect were obtained from genome-wide SNP association and SNP-environment interaction analyses of depression. We then calculated the depression PGIRS for non-depressed individuals, using smoking and alcohol consumption as environmental factors. Using linear regression analysis, we assessed the associations of PGIRS and conventional polygenic risk score (PRS) with lung function (N = 42 886) and cardiac function (N = 1791) in the subjects with or without exposing to smoking and alcohol drinking. We detected significant associations of depression PGIRS with cardiac and lung function, contrary to conventional depression PRS. Among smokers, forced vital capacity exhibited a negative association with PGIRS (β = −0.037, FDR = 1.00 × 10−8), contrasting with no significant association with PRS (β = −0.002, FDR = 0.943). In drinkers, we observed a positive association between cardiac index with PGIRS (β = 0.088, FDR = 0.010), whereas no such association was found with PRS (β = 0.040, FDR = 0.265). Notably, in individuals who both smoked and drank, forced expiratory volume in 1-second demonstrated a negative association with PGIRS (β = −0.042, FDR = 6.30 × 10−9), but not with PRS (β = −0.003, FDR = 0.857). Our findings underscore the profound impact of depression on cardiac and lung function, highlighting the enhanced efficacy of considering gene–environment interactions in PRS-based studies.
- Open Access
- 8 November 2023
- Published by Wiley in Advanced Genetics
- Vol. 4 (4) , 2300192
Insight into the Causal Relationship between Gut Microbiota and Back Pain: A Two Sample Bidirectional Mendelian Randomization Study
Observational studies have shown that alterations in gut microbiota composition are associated with low back pain. However, it remains unclear whether the association is causal. To reveal the causal association between gut microbiota and low back pain, a two‐sample bidirectional Mendelian randomization (MR) analysis is performed. The inverse variance weighted regression (IVW) is performed as the principal MR analysis. MR‐Egger and Weighted Median is further conducted as complementary analysis to validate the robustness of the results. Finally, a reverse MR analysis is performed to evaluate the possibility of reverse causation. The inverse variance weighted (IVW) method suggests thatPeptostreptococcaceae(odds ratio [OR] 1.056, 95% confidence interval [CI] [1.015–1.098],PIVW= 0.010), andLactobacillaceae(OR 1.070, 95% CI [1.026–1.115],PIVW= 0.003) are positively associated with back pain. TheRuminococcaceae(OR 0.923, 95% CI [0.849–0.997],PIVW= 0.033),Butyricicoccus(OR 0.920, 95% CI [0.868 ‐ 0.972],PIVW= 0.002), andLachnospiraceae(OR 0.948, 95% CI [0.903–0.994],PIVW= 0.022) are negatively associated with back pain. In this study, underlying causal relationships are identified among gut microbiota and low back pain. Notably, further research is needed on the biological mechanisms by which gut microbiota influences low back pain.
- 8 November 2023
- Published by Wiley in Advanced Genetics
- Vol. 4 (4) , 2300192
Open AccessInsight into the Causal Relationship between Gut Microbiota and Back Pain: A Two Sample Bidirectional Mendelian Randomization Study
Observational studies have shown that alterations in gut microbiota composition are associated with low back pain. However, it remains unclear whether the association is causal. To reveal the causal association between gut microbiota and low back pain, a two‐sample bidirectional Mendelian randomization (MR) analysis is performed. The inverse variance weighted regression (IVW) is performed as the principal MR analysis. MR‐Egger and Weighted Median is further conducted as complementary analysis to validate the robustness of the results. Finally, a reverse MR analysis is performed to evaluate the possibility of reverse causation. The inverse variance weighted (IVW) method suggests thatPeptostreptococcaceae(odds ratio [OR] 1.056, 95% confidence interval [CI] [1.015–1.098],PIVW= 0.010), andLactobacillaceae(OR 1.070, 95% CI [1.026–1.115],PIVW= 0.003) are positively associated with back pain. TheRuminococcaceae(OR 0.923, 95% CI [0.849–0.997],PIVW= 0.033),Butyricicoccus(OR 0.920, 95% CI [0.868 ‐ 0.972],PIVW= 0.002), andLachnospiraceae(OR 0.948, 95% CI [0.903–0.994],PIVW= 0.022) are negatively associated with back pain. In this study, underlying causal relationships are identified among gut microbiota and low back pain. Notably, further research is needed on the biological mechanisms by which gut microbiota influences low back pain.